Refine
Language
- English (2)
Has Fulltext
- yes (2)
Is part of the Bibliography
- no (2)
Keywords
- CVD biomarker (1)
- risk factor progression (1)
- risk factors (1)
Institute
- Ernst Strüngmann Institut (1)
- Medizin (1)
Research on psychopathy has so far been largely limited to the investigation of high-level processes, such as emotion perception and regulation. In the present work, we investigate whether psychopathy has an effect on the estimation of fundamental physical parameters, which are computed in the brain during early stages of sensory processing. We employed a simple task in which participants had to estimate their interpersonal distance from a moving avatar and stop it at a given distance. The face expression of the avatars were positive, negative, or neutral. Participants carried out the task online on their home computers. We measured the psychopathy level via a self-report questionnaire. Regardless of the degree of psychopathy, the facial expression of the avatars showed no effect on distance estimation. Our results show that individuals with a high degree of psychopathy underestimate distance of approaching avatars significantly less (let the avatar approach them significantly closer) than did participants with a lesser degree of psychopathy. Moreover, participants who scored high in Self-Centered Impulsivity underestimate the distance to approaching avatars significantly less (let the avatar approach closer) than participants with a low score. Distance estimation is considered an automatic process performed at early stages of visual processing. Therefore, our results imply that psychopathy affects basic early sensory processes, such as feature extraction, in the visual cortex.
Aims: Averaged measurements, but not the progression based on multiple assessments of carotid intima-media thickness, (cIMT) are predictive of cardiovascular disease (CVD) events in individuals. Whether this is true for conventional risk factors is unclear.
Methods and results: An individual participant meta-analysis was used to associate the annualised progression of systolic blood pressure, total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with future cardiovascular disease risk in 13 prospective cohort studies of the PROG-IMT collaboration (n = 34,072). Follow-up data included information on a combined cardiovascular disease endpoint of myocardial infarction, stroke, or vascular death. In secondary analyses, annualised progression was replaced with average. Log hazard ratios per standard deviation difference were pooled across studies by a random effects meta-analysis. In primary analysis, the annualised progression of total cholesterol was marginally related to a higher cardiovascular disease risk (hazard ratio (HR) 1.04, 95% confidence interval (CI) 1.00 to 1.07). The annualised progression of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol was not associated with future cardiovascular disease risk. In secondary analysis, average systolic blood pressure (HR 1.20 95% CI 1.11 to 1.29) and low-density lipoprotein cholesterol (HR 1.09, 95% CI 1.02 to 1.16) were related to a greater, while high-density lipoprotein cholesterol (HR 0.92, 95% CI 0.88 to 0.97) was related to a lower risk of future cardiovascular disease events.
Conclusion: Averaged measurements of systolic blood pressure, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol displayed significant linear relationships with the risk of future cardiovascular disease events. However, there was no clear association between the annualised progression of these conventional risk factors in individuals with the risk of future clinical endpoints.
